Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
Only the beginning of precision medicine and multiple myeloma.
Precision medicine for MDS, what drugs for which patients?
Monoclonal gammopathy of unknown significance (MGUS) & importance of regularly monitoring patients
Myeloma 2016: Panel discussion on the environment biology of myeloma
Dirk Hose et al.